FUJIFILM Biotechnologies Capabilities Update July 2026: Gene Therapy

Gene and viral therapies are reshaping the future of medicine, but moving these complex products from development to commercial success requires the right expertise, infrastructure, and scalability. In this video, discover how Fujifilm is helping advance viral gene therapy programs through a globally connected network designed to support every stage of the product lifecycle.

Explore key considerations for viral vector development and manufacturing, including process optimization, technology transfer, analytical testing, regulatory readiness, and the challenges of scaling from early clinical phases to commercialization. You'll also gain insight into the technologies, quality systems, and collaborative approaches that help developers navigate an increasingly competitive and rapidly evolving landscape.

From AAV and lentiviral vectors to emerging modalities and advanced manufacturing capabilities, learn how flexible partnerships and integrated expertise can help accelerate progress while supporting product quality, consistency, and patient access.

Watch the full video to explore the future of viral gene therapy manufacturing and commercialization.